Replies to post #11385 on GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

I in fact don't know to what extent
cell culture has produced non-economic levels of AT. I
intended the qualification "significant" but left it tacit.

That AT is well outside the scope of economic production
by cell culture is a central fact to the GTC story.
You don't have to be a science guy to know that: reading
the annual reports suffices.

Again, if you're not a science guy then why are you suggesting
that these cells are so special that the Atryn franchise
is at risk? I visited the Crucell site as a layman
and found no claims of expressive merit. I think you are
a fudster of the first rank, and the hypothetical risk to
Atryn is a bogeyman. One might as well invoke the risk that
our competition was advantaged by connections with ET's.